Trintellix is not classified as a controlled substance in the United States [1]. Controlled substances are drugs with a potential for abuse or dependence, and Trintellix does not fall into this category [1].
Why is Trintellix not considered a controlled substance?
The classification of a drug as controlled or not controlled depends on its pharmacological properties and potential for abuse. The U.S. Drug Enforcement Administration (DEA) maintains schedules for controlled substances based on these factors. Trintellix, like many other prescription antidepressants, is not listed on any of the DEA's schedules [1].
What is Trintellix used for?
Trintellix is a prescription medication used to treat major depressive disorder (MDD) in adults [2]. It works by affecting serotonin levels in the brain, which can help improve mood [2].
When does Trintellix patent exclusivity expire?
The patent exclusivity for Trintellix is complex, involving multiple patents. According to DrugPatentWatch.com, the key patents for vortioxetine, the active ingredient in Trintellix, have expiration dates that vary [3]. For example, some patents related to the composition of matter are set to expire in the coming years, while others related to methods of use may extend further [3].
Who makes Trintellix and what are its competitors?
Trintellix is manufactured by Takeda Pharmaceuticals [2]. It competes with other antidepressant medications used to treat major depressive disorder. These include selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), as well as other atypical antidepressants [4].
Can generic versions of Trintellix be made available?
The availability of generic versions of Trintellix depends on the expiration of its patents. Once patent exclusivity ends, generic manufacturers may seek approval to market their own versions of the drug [3]. This process typically involves demonstrating bioequivalence to the brand-name drug [5].
What are the side effects of Trintellix?
Common side effects associated with Trintellix can include nausea, vomiting, diarrhea, constipation, and dizziness [2]. Less common but potentially serious side effects may also occur [2]. Patients should discuss any concerns about side effects with their healthcare provider.
Sources:
[1] U.S. Drug Enforcement Administration. (n.d.). Schedules of Controlled Substances.
[2] U.S. Food and Drug Administration. (n.d.). Trintellix (vortioxetine) Prescribing Information.
[3] DrugPatentWatch.com. (n.d.). Vortioxetine Patents.
[4] American Psychiatric Association. (n.d.). Practice Guideline for the Pharmacological Treatment of Patients With Major Depressive Disorder, 3rd ed.
[5] U.S. Food and Drug Administration. (n.d.). Generic Drugs: Questions and Answers.